TickerFacts.

Compare

Zhengye Biotechnology Holding Ltd vs Yatsen Holding Ltd

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearZhengye Biotechnology Holding Ltd
ZYBT		Yatsen Holding Ltd
YSG
Year ended2025-12-312025-12-31
Revenue116.36M CNY4.30B CNY
Revenue growth (YoY)-37.6%+26.7%
Gross margin20.5%78.2%
Operating margin-60.6%-4.3%
Net margin-60.0%-1.9%
Net income-69.78M CNY-80.87M CNY
EPS (Diluted)n/a-0.04 CNY
Operating cash flow13.33M CNY-94.66M CNY
Free cash flow12.32M CNY-136.73M CNY
Cash & equivalentsn/a765.38M CNY
Total assets436.47M CNY3.85B CNY
Total liabilities129.76M CNY846.34M CNY
Shareholders' equity306.71M CNY3.00B CNY
Return on year-end equity-22.8%-2.7%
Shares outstandingn/an/a

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearZhengye Biotechnology Holding LtdYatsen Holding Ltd
Latest116.36M CNY
Ended 2025-12-31		4.30B CNY
Ended 2025-12-31
1 year earlier186.36M CNY
Ended 2024-12-31		3.39B CNY
Ended 2024-12-31
2 years earlier211.65M CNY
Ended 2023-12-31		3.41B CNY
Ended 2023-12-31
3 years earlier260.27M CNY
Ended 2022-12-31		3.71B CNY
Ended 2022-12-31
4 years earliern/a5.84B CNY
Ended 2021-12-31